Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 18,414 shares at $11.72 ($216K) on 2019-06-03, disclosed to the SEC on 2019-06-04.
Open-market sale of $216k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.72 | 8,414 | $99K | 45.7% |
| 2 | $11.72 | 8,414 | $99K | 45.7% |
| 3 | $11.63 | 1,586 | $18K | 8.6% |
| Total | $11.71 avg | 18,414 | $216K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |